Rasagiline Tablets

Contract SPE2D2-26-D-0011 is a bilateral firm-fixed-price award issued by the Defense Logistics Agency Troop Support to Golden State Medical Supply, Inc. for the procurement of Rasagiline tablets in 0.5 MG and 1 MG strengths. The contract, effective April 2, 2026, has a total estimated value of $6,637,357.21, covering a base year and four option years. The tablets are manufactured by Carnegie Pharmaceuticals, LLC in Delran, New Jersey, while Golden State Medical Supply, Inc. in Camarillo, California, is responsible for filling and labeling activities. The agreement specifies estimated annual quantities of 5,828 bottles for the 0.5 MG tablets and 35,099 bottles for the 1 MG tablets, with unit pricing slightly increasing in the option years. Delivery is established as FOB Destination, with the government responsible for final acceptance. The contract incorporates extensive FAR and DFARS clauses focusing on supply chain security, including prohibitions on Kaspersky and ByteDance products, as well as strict adherence to the Contractor Code of Business Ethics and Conduct, small business subcontracting plans, and various labor and employment standards.